Supplementary methods: a) Normalization by an internal standard:
The absolute ion counts of the metabolites obtained from the enzyme-membrane reactor and measured in the MS are prone to fluctuations because of flow rate variations or day to day variations of the electrospray-ionization and therefore require normalization against an internal standard. We supplied 3-N-morpholino-propanesulfonic acid (MOPS) to the reactor feed medium, which is a biologically inert buffer and shows good signal intensity.
Flow rate fluctuations can lead to a different dilution of the reactor outlet (fluctuations at S1) or to a different flow rate in the ESI ion source (fluctuations at S2). We have measured the flow rate of the waste streams of our reactor setup which allowed an estimated on the flow splitting at S1 and S2 ( Fig. 1) . We could not detect any major fluctuations at these mixing tees. However, the splitting ratio was not recorded online in the final measurement setup and could theoretically change over the course of an experiment. We therefore analyzed whether an internal standard can compensate for flow-rate fluctuations within in the setup. We doubled or halved the standard flow rates and recorded the influence on MOPS-normalized signals. As shown in Supplementary Fig. 7 , the influence of the flow rate fluctuations in this setup was minor for fluctuations at S1 ( Supplementary Fig. 7a ). It should be emphasized that a different flow rate (by a factor of 2) at S1 doubles or halves the total concentration of e.g. G3P that is measured in the MS after dilution. Normalization against MOPS after a doubled or halved flow rate at S1 only shows a difference in normalized signal intensity of roughly 10% which is rather low compared to twice or half of the G3P signal without normalization. Given the large fluctuations imposed in this control experiment, we felt that these influences were acceptable. The influence of fluctuations at S2 was negligible ( Supplementary Fig. 7b ). In summary, normalization against an internal standard compensates for flow-rate fluctuations within the setup and consequently, varying total ion counts do not impair the measurements. and limit of quantification (LOQ) were calculated using a signal to noise ratio of 3 and 10, respectively.
Supplementary
To obtain concentration values from raw data the ion current from each compound is normalized against the ion current of MOPS. The normalized value is then converted to concentrations using a corresponding normalized calibration curve and the dilution factor is included to obtain real reactor concentrations.
To meet the demand for a broad quantification range, quadratic calibration curves were established ( Supplementary Table 3 ) since the calibration curves for most compounds only showed a linear behavior up to a concentration of approximately 10 µM at the ion source (data not shown). As the coefficients of the quadratic terms were generally two orders of magnitude smaller than those of the linear terms, they only became relevant for high compound concentrations, meaning that they were essentially zero for very low concentrations. Using quadratic calibration curves allowed us to cover a concentration range of at least three orders of magnitude for all compounds with a maximum reactor concentration of 2.5 mM. An exception was glucose which covered a range up to 5 mM and NADH which covered a range up to 1.25 mM. Within these ranges quantification errors were generally smaller than 10% regardless whether high or low concentrations were considered. Supplementary Table 3 : Calibration data for glycolytic intermediate quantification.
Limit of detection (LOD, at a signal to noise ration of S/N=3) and limit of quantification (LOQ, S/N=10) refer to concentrations in the reactor; hence, the concentrations measured at the ion-source are 100 times lower. Regression data were obtained by fitting to a quadratic calibration curve y=ax 2 +bx. Note that the coefficient in the quadratic term is always two to three orders of magnitude smaller than the coefficient in the linear term, indicating that the quadratic term is only a small correction for high metabolite concentrations. A 3PG calibration curve was used to quantify the overlapping 2PG/3PG pool and G6P to quantify the overlapping G6P/F6P pool (see also 1d). 19, 20 and can occur if MRM transitions are not specific for a certain compound. For the set of metabolites analyzed here, the two compound sets G6P/F6P as well as 2PG/3PG could not be distinguished from each other since they showed exactly the same fragmentation patterns and intensities. Subsequently, only the G6P/F6P and 2PG/3PG pools rather than individual concentrations were determined in the following analyses.
The two compounds FBP and GAP showed overlapping signals at the MRM transition of DHAP (Supplementary Fig. 8a ) but could be distinguished from DHAP using unique fragment ions. The "false positive" signal of FBP at the DHAP transition was very low and could be neglected. The "false positive" signal of the phosphate ion of GAP at the DHAP transition was only 30% lower than the DHAP signal itself ( Supplementary Fig. 8a) . Here, a unique fragmentation pattern of GAP could be used for its exact quantification and allowed for calculating the contribution of the overlapping GAP signal. To confirm this, we measured first samples containing equimolar amounts of GAP and DHAP, which showed, as expected, higher signals at the DHAP-transition compared to samples containing the same amount of DHAP only. When the overlapping GAP signal was subtracted from the signal of the equimolar mixture, the corrected values were identical to those measured for DHAP alone, indicating that the correction method was accurate (Supplementary Fig. 8b ).
In this study, the DHAP signal was corrected for the overlapping GAP signal as soon as GAP could be quantified in the sample. However, please note that in the vast majority of scenarios described here, the GAP concentration remained below the LOQ and correction was therefore not necessary. However, we can correct the signal for false positive fractions in case reliable GAP concentrations are measured in future experiments.
A similar observation was made for the NAD + and NADH signals. NADH showed an overlapping signal with the MRM-transition of NAD + , which could be corrected by subtracting the false positive signal of NADH, as shown by the identity of a curve obtained from NAD + alone and one obtained from measuring the NAD + signal from an equimolar mix of NAD + and NADH and then subtracting the NADH-specific contribution (Supplementary Fig. 8c-d) . In this study, the NAD + signal was corrected for the overlapping NADH signal when NADH was present above the LOQ. for the method 21 . An understanding of the impact of ion suppression is essential for the validation of the presented method 21 and particularly for online measurement of glycolytic intermediates since the quantitative measurements will be performed in a dynamically changing matrix without prior chromatographic separation. In order to analyze potential matrix effects, standard addition of pure compounds to two physiological samples from in vitro batch conversion of glucose and ATP was performed as reported previously 22 . Briefly, two samples were taken (after 30 min and 120 min) from a 10 mL batch reaction at 37°C (100 mM NaHCO 3 pH 7.7; 5 mM Samples were analyzed using a syringe pump at 30 μL min -1 . The increase in signal for the specific compound was determined, leading to two calibration curves (one for each original sample) with different intercepts on the ordinate depending on how much of the specific compound was in the original sample to start with. Such standard addition curves were recorded for all compounds in both samples ( Supplementary Fig. 9 ). As normalized signal intensities were still in the linear range, experiments were evaluated by calculating the relative deviation of the slope (in percent) of standard addition experiments in the two matrices.
The effect of ion suppression for the specific compound was then estimated from the ratio of the two calibration curves, each recorded in a different but still typical concentration matrix (Supplementary Table 4) . In the absence of any ion suppression effect, the two slopes should be identical irrespective of the background;
the ratio of the two slopes should be 1 (100%). The obtained slope ratios varied between 94.7% for pyruvate and 106.5% for ADP. In summary, these results indicated that in the system under study ion suppression effects were only a minor issue, as slopes were nearly identical and the added compounds only showed a minor impact onto the signals of the non-added compounds (Supplementary Fig. 9 ).
signal intensities of the non-added compounds are shown (in total 10 signal intensities per compound: two experiments, five measurements each (first, no addition, and then 4 additions of the specific compound). Note that the two sets of concentration for the added compound have to differ, as the two samples used for standard addition contained different concentrations of the corresponding compound.
The two slopes for the added compound were calculated and the slope ratio is shown
in Supplementary Table 4 . The reactor itself showed a dead time of 0.5 min when operated without the dilution device (S1, T, and S2, see Fig. 1 ). The dilution device prolonged the dead time by 1 min because of the tubing. The concentration time course obtained due to the residence time distribution in the reactor was hardly changed by the dilution device, indicating that the dilution did not cause significant disturbances of the signal. When the reactor was fitted with a membrane to retain the enzymes of the CFX, the curve flattened slightly and showed a retarded peak, but residence time profiles were reproducible for the 10 glycolytic metabolites and 5 cofactors studied here ( Supplementary Fig. 10) . We are currently working on protocols for the mathematical correction of this slight change in signal from reactor interior to ESIchamber, but argue that this minor effect is of no relevance for the results presented in this work.
Once the separate items of the setup had been characterized with G3P only, the results were confirmed for all compounds with the final setup. Here, the dynamics of 200 μL pulses of 4 compounds (12.5 μM each) was recorded for 1 h. Primary data were first normalized against MOPS and are shown as signal intensities relative to the maximum signal intensity of each compound (Supplementary Fig. 10b ). Fig. 11) . The beneficial effect of longer dwell times becomes obvious at a dwell time of 1000 ms and 2500 ms, where the noise is about 60 to 100 times lower than the signal. The analysis in this study was performed at 0.125 Hz (7.5 measurements per minute) which in our view was a good tradeoff between data density and signal quality, but an increase in time-resolution by a factor of five would be easily possible if required, with only minor consequences for data quality. Higher time-resolutions would be also possible, but only at the expense of data quality. Figure 11 : The impact of measurement frequency on data quality. dynamic metabolite time courses were calculated as described previously 23, 24 . The method has two limitations: First, it assumes linear rate equations in the relevant substrate concentration ranges, which is not necessarily the case. However, the influence of non-linearity is usually limited 24 . Second, the method is sensitive to measurement inaccuracies 25 . However, we argue that this problem is eliminated to a large extent by metabolic real-time analysis, which gives continuous, high frequency data with high consistency when compared to traditional enzyme-based assays or discretely withdrawn samples for HPLC-MS analysis. Briefly, the method is applied as follows: a set of coefficients α j can be calculated for a K-enzyme pathway from For FCC calculation the time period from 5.5 -19 min from Fig. 3 comprising 100 data points was used which showed the largest dynamic changes, thereby minimizing the collinearity of regression coefficients.

For the pathway studied here, the following assumptions were made: G6P and F6P are in equilibrium and were lumped into one reaction; 2PG/3PG and PEP were in equilibrium ( Supplementary Fig. 2 ) and are also lumped into one reaction; as GAP was always below the LOQ it was assumed to react rapidly to 1,3-PG and therefore GAP-DH and PGK were also lumped into one reaction. The reactions from ADP to AMP as well as from DHAP to G3P were neglected and consequently the pathway was treated as linear. As the NAD + time course was constant it could be considered as a constant external metabolite and was therefore omitted from FCC calculation.
Based on these assumptions the pathway can be described by the following stoichiometric matrix: Table 5 ) by adding the next enzyme when steady concentrations of DHAP were reached. fructosebisphosphate, 0.5 mM NADH, 1.7 U mL -1 ; LDH: 5 mM pyruvate, 0.5 mM NADH. The slope of the linear part of the curve recorded at 340 nm and the protein concentration was used to calculate the specific enzyme activity in the CFX. The activities of commercially available enzymes were different from those given by the supplier and the conversion factors can be found in Supplementary Table 2 .
